Among the vaccinated patients, 36.6% were protected against diphtheria, 89.9% against tetanus, 67.3% were seropositive for anti-PT, 16.3% had titers indicative of pertussis infection or vaccination in the past few years and 5.1% titers indicative of infection or vaccination in the past few months. This evidence concerns the gene F2 and tetanus.